Driving & Preclinical AD

Roe, C.M., Stout, S.H., Rajasekar, G., Ances, B.M., Head, D.M., Benzinger, T.L.S., Williams, M.M., Davis, J.D., Ott, B.R., Warren, D.K., Babulal, G.M. (2019). A 2.5 Year Longitudinal Assessment of Naturalistic Driving in Preclinical Alzheimer Disease. Journal of Alzheimer’s Disease 68(4), 1625-1633.

Roe, C. M., Babulal, G. M., Stout, S. H., Carr, D. B., Williams, M. M., Benzinger, T. L., … & Morris, J. C. (2018). Using the A/T/N Framework to Examine Driving in Preclinical Alzheimer’s Disease. Geriatrics3(2), 23.

Allison, S., Babulal, G. M., Stout, S. H., Barco, P. P., Carr, D. B., Fagan, A. M., … & Head, D. (2018). Alzheimer Disease Biomarkers and Driving in Clinically Normal Older Adults. Alzheimer Disease & Associated Disorders32(2), 101-106.

Stout, S. H., Babulal, G. M., Ma, C., Carr, D. B., Head, D. M., Grant, E. A., … & Roe, C. M. Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association. (2018);13:7, P1207-P1208.

Babulal GM, Stout SH, Head D, Holtzman DM, Fagan AM, Morris JC, Roe CM. Neuropsychiatric symptoms and alzheimer’s disease biomarkers predict driving decline: brief report. Journal of Alzheimer’s disease. 2017.

Babulal GM, Stout SH, Head DM, Fagan AM, Benzinger TLS, Ott BR, Carr DB, Webb M, Traub CM, Addison A, Holtzman DM, Morris JC, Warren DK, Roe CM. A naturalistic study of driving behavior in older adults and preclinical Alzheimer disease: A pilot study. Journal of Applied Gerontology. 2017. (doi: 10.1177/0733464817690679)

Roe CM, Babulal GM, Head DM, Stout SH, Vernon EK, Ghoshal N, Garland B, Barco PP, Williams MW, Johnson A, Fierberg R, Fague MS, Xiong C, Mormino E, Grant EA, Holtzman DM, Benzinger TLS, Fagan AM, Ott BR, Carr DB, Morris JC. Preclinical Alzheimer’s disease and longitudinal driving decline. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. 2017;3:74-82. (doi: 1016/j.trci.2016.11.006)

Ott BR, Jones RN, Noto RB, Yoo DC, Snyder PJ, Bernier JN, Carr DB, Roe CM. Brain amyloid in preclinical Alzheimer’s disease is associated with increased driving risk. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2016;6:136-142. (doi:1016/j.dadm.2016.10.008)

Carr DB, Barco PP, Babulal GM, Stout SH, Johnson AM, Xiong C, Morris JC, Roe CM. Association of Functional Impairments and Co-Morbid Conditions with Driving Performance among Cognitively Normal Older Adults. PLoS ONE. 2016;11:12:e0167751. (doi: 0.1371/journal. pone.0167751)

Roe, CM, Barco, PP, Head, DM, Ghoshal, N, Selsor, N, Babulal, GM, Fierberg R, Vernon, EK, Shulman, N, Johnson, A, Fague, S, Xiong, C, Grant, EA, Ott, BR, Holtzman, DM, Benzinger, TL, Fagan, AM, Carr, DB, Morris, JC. Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals. Alzheimer disease and associated disorders. 2016;31:1:69-72.

Vernon EK, Babulal GM, Head, D, Carr, DB, Ghoshal N, Barco P, Morris JC, & Roe CM.  Adults 65 and older use potentially distracting electronic devices while driving. Journal of the American Geriatrics Society 2015;63:1251-1253.